5e9d4c766b9b266f58c1a99fBRONCAST Broncast 5 mg paediatric chewahttps://store.whites.net/s/5e5b8eb5e1a30016118f588f/5e9d4c766b9b266f58c1a99f/01062850950062341721100010192901021gynzoqd32c1410m.jpgindicated in the treatment of asthma as add-on therapy in those 6 to 14 year old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom 'as-needed' short-acting β-agonists provide inadequate clinical control of asthma.25710
مع كل عملية شراء مؤهلة، ستحصل على نقاط الولاء. ويمكنك استبدال هذه النقاط للحصول على مجموعة متنوعة من المكافآت، مثل الخصومات، والعروض الحصرية، أو حتى المنتجات المجانية.
indicated in the treatment of asthma as add-on therapy in those 6 to 14 year old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom 'as-needed' short-acting β-agonists provide inadequate clinical control of asthma.
indicated in the treatment of asthma as add-on therapy in those 6 to 14 year old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom 'as-needed' short-acting β-agonists provide inadequate clinical control of asthma.
indicated in the treatment of asthma as add-on therapy in those 6 to 14 year old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom 'as-needed' short-acting β-agonists provide inadequate clinical control of asthma.
indicated in the treatment of asthma as add-on therapy in those 6 to 14 year old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom 'as-needed' short-acting β-agonists provide inadequate clinical control of asthma.